Yuk Tung

1.6k total citations
9 papers, 398 citations indexed

About

Yuk Tung is a scholar working on Surgery, Otorhinolaryngology and Oncology. According to data from OpenAlex, Yuk Tung has authored 9 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Surgery, 3 papers in Otorhinolaryngology and 3 papers in Oncology. Recurrent topics in Yuk Tung's work include Head and Neck Cancer Studies (3 papers), Head and Neck Surgical Oncology (3 papers) and Clinical practice guidelines implementation (1 paper). Yuk Tung is often cited by papers focused on Head and Neck Cancer Studies (3 papers), Head and Neck Surgical Oncology (3 papers) and Clinical practice guidelines implementation (1 paper). Yuk Tung collaborates with scholars based in China, Hong Kong and Canada. Yuk Tung's co-authors include Anne W.M. Lee, Wai Tong Ng, Sophie Marguet, Hai-Qiang Mai, Jun Ma, Dora L.�W. Kwong, Jean Bourhis, Pei‐Yu Huang, Kwan-Hwa Chi and Guopei Zhu and has published in prestigious journals such as Journal of Clinical Oncology, Cochrane Database of Systematic Reviews and Radiotherapy and Oncology.

In The Last Decade

Yuk Tung

9 papers receiving 393 citations

Peers

Yuk Tung

OTORH

SURGE

ONCOL

PRM

MB

Mai‐Yee Luk China

David Skarsgard Canada

Zeynep Özsaran Türkiye

P. Delvecchio United States

Mario Šekerija Croatia

Stephen D. Clark United States

Ian Lord United Kingdom

Vaibhav Gupta Canada

Katrina Hueniken Canada

Lizzy Sunny India

Mai‐Yee Luk China

Yuk Tung

132 ×0.6

OTORH

119 ×0.7

SURGE

229 ×2.0

ONCOL

105 ×1.1

PRM

51 ×1.5

MB

Citations per year, relative to Yuk Tung Yuk Tung (= 1×) peers Mai‐Yee Luk

Countries citing papers authored by Yuk Tung

Since Specialization

Citations

This map shows the geographic impact of Yuk Tung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuk Tung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuk Tung more than expected).

Fields of papers citing papers by Yuk Tung

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuk Tung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuk Tung. The network helps show where Yuk Tung may publish in the future.

Co-authorship network of co-authors of Yuk Tung

This figure shows the co-authorship network connecting the top 25 collaborators of Yuk Tung. A scholar is included among the top collaborators of Yuk Tung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuk Tung. Yuk Tung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Lee, Shing Fung, Cheuk‐Wai Choi, Ka Man Cheung, et al.. (2021). External Validation of a Nomogram to Predict Survival and Benefit of Concurrent Chemoradiation for Stage II Nasopharyngeal Carcinoma. Cancers. 13(17). 4286–4286. 5 indexed citations

2.

Huang, Yu‐Te, et al.. (2020). How Intersectional Are Mental Health Interventions for Sexual Minority People? A Systematic Review. LGBT Health. 7(5). 220–236. 32 indexed citations

3.

Ribassin-Majed, Laureen, Sophie Marguet, Anne W.M. Lee, et al.. (2017). What Is the Best Treatment of Locally Advanced Nasopharyngeal Carcinoma? An Individual Patient Data Network Meta-Analysis. Journal of Clinical Oncology. 35(5). 498–505. 241 indexed citations

4.

Tung, Yuk, et al.. (2016). Comparison of clinical efficacy and renal safety of telbivudine and entecavir in chronic hepatitis B patients receiving cytotoxic chemotherapy. Journal of Digestive Diseases. 17(5). 325–333. 2 indexed citations

5.

Zhang, Hong Wei, et al.. (2014). Cordyceps sinensis (a traditional Chinese medicine) for treating chronic kidney disease. Cochrane Database of Systematic Reviews. 2014(12). CD008353–CD008353. 53 indexed citations

6.

Sze, Wing Kin, et al.. (2013). Primary yolk sac tumour of the urinary bladder: A case report and review of the literature. Oncology Letters. 7(1). 199–202. 13 indexed citations

7.

Lo, Sing-Hung, et al.. (2009). The implementation of an end-of-life integrated care pathway in a Chinese population. International Journal of Palliative Nursing. 15(8). 384–388. 25 indexed citations

8.

Yau, Tsz‐Kok, Inda Soong, Ka‐On Lam, et al.. (2009). Toxicity of docetaxel plus cyclophosphamide as adjuvant therapy for breast cancer in Chinese patients – the Hong Kong experience. Asia-Pacific Journal of Clinical Oncology. 5(2). 123–128. 4 indexed citations

9.

Teo, Peter M.L., Jack Fowler, To Wai Leung, et al.. (2000). Improved local control for early T-stage nasopharyngeal carcinoma – a tale of two hospitals. Radiotherapy and Oncology. 57(2). 155–166. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact